Archives: Agenda

Understanding when China makes sense, when it doesn’t, and how to build a practical operational pathway

• Evaluating when China is the right fit for global development strategies
• Weighing the benefits, risks and timelines of China-linked studies
• Exploring Australia and other ICH-aligned pathways into the US market
• Comparing China, Australia and Central & Eastern Europe for trial execution
• Aligning clinical operations, CMC, manufacturing and quality strategies
• Sharing practical lessons from sponsors currently assessing China expansion

2 x Biopharma panel seats available

1 x Vendor panel seat available

• Understanding how clinical trials continue during war and infrastructure disruption
• Managing patient safety supply chain and data integrity under extreme conditions
• Applying lessons from Ukraine to improve resilience and contingency planning

• Exploring the meaning of risk sharing across roles
• Supporting balance between procurement and R&D priorities
• Strengthening partnership models through transparency

1 x Biopharma panel seat available

1 x Vendor panel seat available

• Understanding how the new UK framework is working in practice 6 months after implementation
• Identifying key operational changes, including approvals, consent, and trial setup
• Clarifying how sponsors can take advantage of faster pathways while staying compliant

Reserved for NIHR